Visit COVID-19 resources

[Skip to Content]

Brolucizimab—leading an era of structural revolution for long-term VEGF suppression – (Eye Journal)

Sep 19
2019

Eye, Published online: 19 September 2019; doi:10.1038/s41433-019-0583-z Brolucizimab—leading an era of structural revolution for long-term VEGF suppression

  • 19 September 2019

Abicipar pegol—a novel anti-VEGF therapy with a long duration of action – (Eye Journal)

Sep 19
2019

Eye, Published online: 19 September 2019; doi:10.1038/s41433-019-0584-y Abicipar pegol—a novel anti-VEGF therapy with a long duration of action

  • 19 September 2019

Circumpapillary and macular vessel density assessment by optical coherence tomography angiography in eyes with temporal hemianopia from chiasmal compression. Correlation with retinal neural and visual field loss – (Eye Journal)

Sep 18
2019

Eye, Published online: 18 September 2019; doi:10.1038/s41433-019-0564-2 Circumpapillary and macular vessel density assessment by optical coherence tomography angiography in eyes with temporal hemianopia from chiasmal compression. Correlation with retinal neural and visual field loss

  • 18 September 2019

Cavitary retinoblastoma: clinical observations – (Eye Journal)

Sep 18
2019

Eye, Published online: 18 September 2019; doi:10.1038/s41433-019-0581-1 Cavitary retinoblastoma: clinical observations

  • 18 September 2019

Risk of acute stroke in patients with retinal artery occlusion: a systematic review and meta-analysis – (Eye Journal)

Sep 16
2019

Eye, Published online: 16 September 2019; doi:10.1038/s41433-019-0576-y Risk of acute stroke in patients with retinal artery occlusion: a systematic review and meta-analysis

  • 16 September 2019